Sattar, N., McGuire, D. K., Pavo, I., Weerakkody, G. J., Nishiyama, H., Wiese, R. J., & Zoungas, S. (2022). Tirzepatide cardiovascular event risk assessment: A pre-specified meta-analysis. Nature medicine, 28(3), 591-598. https://doi.org/10.1038/s41591-022-01707-4
Chicago-Zitierstil (17. Ausg.)Sattar, Naveed, Darren K. McGuire, Imre Pavo, Govinda J. Weerakkody, Hiroshi Nishiyama, Russell J. Wiese, und Sophia Zoungas. "Tirzepatide Cardiovascular Event Risk Assessment: A Pre-specified Meta-analysis." Nature Medicine 28, no. 3 (2022): 591-598. https://doi.org/10.1038/s41591-022-01707-4.
MLA-Zitierstil (9. Ausg.)Sattar, Naveed, et al. "Tirzepatide Cardiovascular Event Risk Assessment: A Pre-specified Meta-analysis." Nature Medicine, vol. 28, no. 3, 2022, pp. 591-598, https://doi.org/10.1038/s41591-022-01707-4.